The Experts below are selected from a list of 58737 Experts worldwide ranked by ideXlab platform

Sh Mehrpisheh - One of the best experts on this subject based on the ideXlab platform.

  • Propose a Regulatory Framework for Stem Cell Research based on Ethical Guideline
    International journal of medical toxicology and forensic medicine, 2015
    Co-Authors: Sh Mehrpisheh
    Abstract:

    Background : Stem cell research has emerged as one of the most promising research areas in modern biomedicine. However, despite much promise the use and derivation of these cells in many countries is Ethically challenging. Stem cell laws are the law, rules, and policy governance concerning the sources, research, and use of stem cells in treatment of human diseases. These laws have been the source of much  controversy  and vary significantly by country. Methods: Google search was used to find information on the Web about stem cell research in world countries and Iran. Discussion: An Ethical Guideline in Iran has been recently approved. In compiling this Guideline the accumulated experience of the governments and Islamic laws and Persian culture and special look to human health as well as the moral status of the human embryo has been used. Some part of this Guideline is licensed research can only take place on embryos created  in vitro : embryos that have developed from eggs fertilized outside the body. Most embryos used in stem cell research are embryos that initially created in order to use in fertility treatment, but not used. These 'surplus' IVF embryos, if donated with the full consent of the parents, can be used for research. Conclusion: We propose a regulatory framework based on this moral Guideline one of our suggestion for regulation of stem cell research is legal medicine organization.

Rosan Yoshida - One of the best experts on this subject based on the ideXlab platform.

  • Zen and Science: Zen as an Ethical Guideline for Scientists’ Conducts
    Handbook of Zen Mindfulness and Behavioral Health, 2017
    Co-Authors: Rosan Yoshida
    Abstract:

    Since it was first introduced to the West in early 1900s, many scholars and practitioners have discussed Zen along with sciences in various foci. What has not been fully discussed, however, is the potential role of Zen as an overarching Ethical Guideline for the behavior of scientists as well as the consumers of science. In this chapter, Reverent Rosan Yoshida Roshi argues the importance of establishing and adhering to such a Guideline and states that Zen is particularly suitable to promote it. First, Yoshida argues that unlike our image of science as being value-free and bias-free, science is a human enterprise which is extremely vulnerable to our tendency to prioritize the demands from ego (i.e., me-ism/selfishness/sinfulness), which is often manifested as utilitarianism, materialism, militarism, and the money-ism. Yoshida then states that these tendencies are destructive and threatens the entire ecosystem. According to Yoshida, Zen teachings can counteract or mitigate this tendency as it emphasizes collective wholeness as its ultimate goals and presents remedies for lessening these egocentric demands.

Nasrin Nejad Sarvari - One of the best experts on this subject based on the ideXlab platform.

  • Embryonic stem cells research; legislation necessity
    Medical Ethics Journal, 2011
    Co-Authors: Nasrin Nejad Sarvari
    Abstract:

    Nowadays, the subject of embryonic stem cells has engaged In addition to biologists and physicians other specialists including medical ethicists, politicians, statesmen, lawyers. There is a wide range of Ethical and legal issues about producing and using of these exclusive cells in research. Clearly legislation of stem cell researches guarantees and prevents from probable unfavorable sideffects and instrumental using of the embryo; in addition it preserves the position and value of the embryo. The gradual process of legislation in embryonic cell using in comparison to accelerate using of these cells in medicine will make a legal gap that will impair human dignity and the right to life and their compensations will be very difficult. Therefore, it is necessary to legislate about these cells before development of these researches. One of the first countries that have achieved technology of stem cell is Iran but yet we don't have Ethical Guideline and codified law about stem cells. In other countries that have had acceleration in this scientific field from beginning of stem cells research even before beginning of research. They have spent a long time on legislation and experimental activity. In this article, we talk about different sides of these technologies. We review briefly legislations status in international communities and some developed countries and finally we state key points in these laws and remind necessity of legislation of stem cell research in Iran.

Leila Afshar - One of the best experts on this subject based on the ideXlab platform.

  • Ethics of research on stem cells and regenerative medicine: Ethical Guidelines in the Islamic Republic of Iran.
    Stem Cell Research & Therapy, 2020
    Co-Authors: Leila Afshar, Hamid Reza Aghayan, Jila Sadighi, Babak Arjmand, Seyed-mahmoud Hashemi, Mohsen Basiri, Reza Omani Samani, Mohammad Kazemi Ashtiani, Seyed-ali Azin, Ensiyeh Hajizadeh-saffar
    Abstract:

    BACKGROUND Regenerative medicine plays a major role in biomedicine, and given the ever-expanding boundaries of this knowledge, numerous Ethical considerations have been raised. MAIN TEXT Rapid advancement of regenerative medicine science and technology in Iran, emerged the Iranian National Committee for Ethics in Biomedical Research to develop a comprehensive national Ethical Guideline. Therefore, the present Ethical Guideline which comprises eleven chapters was developed in 2019 and approved in early 2020. The titles of these chapters were selected based on the Ethical considerations of various aspects of the field of regenerative medicine: (1) Ethical principles of research on stem cells and regenerative medicine; (2) Ethical considerations for research on stem cells (embryonic stem cells, epiblast stem cells, tissue-specific stem cells, stem cells derived from transdifferentiation, induced pluripotent stem cells [iPSCs], germline pluripotent stem cells, germline stem cells, and somatic cell nuclear transfer [SCNT] stem cells); (3) Ethical considerations for research on somatic cells in regenerative medicine (adult somatic cells, fetal tissue somatic cells, and somatic cells derived from pregnancy products [other than fetus]); (4) Ethical considerations for research on gametes in regenerative medicine; (5) Ethical considerations for research related to genetic manipulation (human and animal) in regenerative medicine; (6) Ethical considerations for research on tissue engineering in regenerative medicine; (7) Ethical considerations for pre-clinical studies in regenerative medicine; (8) Ethical considerations for clinical trials in regenerative medicine; (9) Ethical considerations for stem cells and regenerative medicine bio-banks; (10) Ethical considerations for privacy and confidentiality; and (11) Ethical considerations for obtaining informed consent. CONCLUSION This article discusses the process of developing the present Ethical Guidelines and its practical points. We hope that it can play an important worldwide role in advancing ethics of research on stem cells and regenerative medicine.

  • Ethical challenges in the relationship between the pharmacist and patient in Iran
    International Journal of Human Rights in Healthcare, 2020
    Co-Authors: Kourosh Delpasand, Saeid Nazari Tavakkoli, Mehrzad Kiani, Mahmoud Abbasi, Leila Afshar
    Abstract:

    Purpose Based on the developmental process of pharmacy in medical relationships, it is essential to pay attention to Ethical issues in this field and develop a good pharmacist–patient relationship. The present study aimed to mention the frequency of Ethical challenges of pharmacy in Iran as a fundamental step towards designing a practical Ethical Guideline for professionals. Design/methodology/approach In this observational study, data were collected using a two-part questionnaire with 64 items developed after examining relevant texts and conducting unstructured interviews with pharmacy specialists. The first part determined the frequency of Ethical challenges that the pharmacist confronts, using 43 short scenarios, whereas the second part comprised 21 questions with short answers. For validation, the questionnaire was sent to 20 medical ethics specialists who were familiar with issues in pharmacy ethics. Findings Data were collected from 48 members of the Iranian Association of Pharmacists (Working Group of Hospital Pharmacists). and the frequency of Ethical challenges was determined. The most frequent issues were patient's request for over-the-counter drugs, asking about their lab results, asking drug for another person and returning the drug. Research limitations/implications One of the limitation of our study is its population, there were hospital pharmacist, other pharmacist such as community pharmacist may face different challenges. Practical implications The finding of this study could lead the policymakers to develop Ethical Guidelines for pharmacy practices. Social implications The pharmacist–patient relationship is one of the important aspects of health system, and therefore regulating this relationship based on the professional ethics Guidelines could have a positive impact on therapeutic relationships. Originality/value Results showed that designing codes of ethics and practical Guidelines based on the frequency of the noted challenges enhances the quality of treatment, improves the pharmacist–patient relationship, increases the level of cooperation and decreases patient complaints.

Joy Yueyue Zhang - One of the best experts on this subject based on the ideXlab platform.

  • Regulatory Framework and Early Administrative Rationales
    The Cosmopolitanization of Science, 2012
    Co-Authors: Joy Yueyue Zhang
    Abstract:

    In order to examine how the practice of China’s stem cell research has evolved through transnational exchanges, or how research in China has been ‘cosmopolitanized’, it is necessary first to understand how the scientific system functioned at the onset of stem cell research. This provides us with a point of reference to identify subsequent changes in China. Therefore this chapter gives an overview of the regulatory background in the early stages of stem cell research. By early stages, I mean the period between China’s immediate response to cloning techniques after the birth of Dolly in 1997 and the launch of the first Ethical Guideline in 2003. Not only does this stage cover the first third of the time period in China’s stem cell development (late 1990s until today) but, more importantly, administrative measures and their consequences during this period also form the basis of current discussions on advancing China’s bio-governance.